Crohn's Disease Clinical Trials near Cleveland, OH
22 studies for Crohn's Disease are recruiting at 31 sites within 50 miles of Cleveland, Ohio, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Crohn's Disease trials in the US or all trials near Cleveland.
Recruiting now
Crohn's Disease studies enrolling near Cleveland
- A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819878
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest sites: Cleveland Clinic Foundation (Cleveland, OH); Gastro Intestinal Research Institute of Northern Ohio (Westlake, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Non-nutritive Sweeteners in Inflammatory Bowel Disease
NCT07769437
- Interventional
- Ages 18 to 70 years
- Sex: All
- Accepts healthy volunteers
Nearest sites: University Hospitals Cleveland Medical Center (Cleveland, OH); UH Westlake Health Center (Westlake, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
NCT07852273
- Interventional
- Ages 18 to 75 years
- Sex: All
- Accepts healthy volunteers
Nearest sites: University Hospitals Cleveland Medical Center (Cleveland, OH); UH Westlake Health Center (Westlake, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
NCT07184931
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest sites: University Hospitals Cleveland Medical Center-Site Number: 8400073 (Cleveland, OH); North Shore Gastroenterology Research-Site Number: 8400130 (Westlake, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Precise Infliximab Exposure and Pharmacodynamic Control
NCT05660746
- Phase 2/3
- Ages 6 to 22 years
- Sex: All
Nearest site: Cleveland Clinic Children's Hospital (Cleveland, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
NCT05781152
- Phase 4
- Ages 6 to 17 years
- Sex: All
Nearest site: UH/Rainbow Babies and Children's Hospital (Cleveland, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
NCT05995353
- Phase 3
- Ages 2 to 17 years
- Sex: All
Nearest site: Cleveland Clinic - Cleveland /ID# 256453 (Cleveland, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
NCT06332534
- Phase 3
- Ages 2 to 17 years
- Sex: All
Nearest site: UH Cleveland Medical Center /ID# 262188 (Cleveland, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
NCT06670638
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: Cleveland Clinic Foundation (Cleveland, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Treatment of Moderate to Severe Refractory Crohn's Disease
NCT06721962
- Phase 1/2
- Ages 18 to 65 years
- Sex: All
Nearest site: Cleveland Clinic (Cleveland, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819891
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: Cleveland Clinic Foundation (Cleveland, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD
NCT07680283
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: Cleveland Clinic (Cleveland, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
NCT06045754
- Phase 4
- Ages 18 to 70 years
- Sex: All
Nearest sites: Gastro Intestinal Research Institute of Northern Ohio, LLC. (Westlake, OH); Great Lakes Gastroenterology Research, LLC (Mentor, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
NCT06581328
- Phase 4
- Ages 18 to 80 years
- Sex: All
Nearest sites: NorthShore Gastroenterology Research, LLC (Westlake, OH); Great Lakes Gastroenterology Research, LLC (Mentor, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
NCT06810518
- Observational
- Ages 22 years and older
- Sex: All
- Accepts healthy volunteers
Nearest site: Gastro Intestinal Research Institute of Northern Ohio, (Westlake, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
NCT06937099
- Phase 3
- Ages 18 to 70 years
- Sex: All
Nearest site: Gastro Intestinal Research Institute of Northern Ohio, LLC (Westlake, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
NCT07184944
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: North Shore Gastroenterology Research-Site Number: 8400130 (Westlake, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
NCT07697456
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Gastro Intestinal Research Institute of Northern Ohio /ID# 283860 (Westlake, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
NCT06233461
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Great Lakes Gastroenterology Research, LLC (Mentor, OH)
- Distance to nearest recruiting site
- ~22 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
NCT06430801
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: Great Lakes Gastroenterology Research, LLC ( Site 5016) (Mentor, OH)
- Distance to nearest recruiting site
- ~22 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
NCT07499232
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Great Lakes Gastroenterology Research, LLC (Mentor, OH)
- Distance to nearest recruiting site
- ~22 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
NCT07577843
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Great Lakes Gastroenterology Research, LLC (Mentor, OH)
- Distance to nearest recruiting site
- ~22 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a Crohn's Disease clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.